Researchers from Postnova have used asymmetrical flow field-flow fractionation coupled to AF4-MALS to successfully characterize a polydisperse cellulose nanocrystal for size and thickness.
Photo Credit: GiraoScience/stock.adobe.com
Researchers from Postnova have used asymmetrical flow field-flow fractionation coupled to multi-angle light scattering (AF4-MALS) to successfully characterize a polydisperse cellulose nanocrystal (CNC) for size and thickness (1).
Nanocrystal research has been an area of significant interest because of a growing range of applications in advanced materials, biomedical, environmental, optical, and semiconductor fields. Their attractive properties, including low thermal expansion, optical transparency, renewability, biodegradability, low toxicity, and low cost, lend themselves to many industrial applications, such as polymer reinforcing, photonic crystals, drug delivery, water treatment membranes, and biomedical devices (2). However, a thorough size characterization is necessary as their rheological and control processing properties can be affected by their size, shape, and surface area.
Current bulk characterization techniques for crystal characterization include transmission electron microscopy (TEM), atomic force microscopy (AFM), and dynamic light scattering (DLS), however, AF4-MALS offers a significant improvement in analysis time as well as resolution, according to the study authors (3).
Researchers used a cellulose nanocrystal sample, isolated from softwood sulphite pulp, and analyzed it using AF4-MALS to measure the length and thickness of the crystals as a function of size. The results were then confirmed using the established method of AFM analysis. Results indicated that AF4-MALS was successfully employed to characterize the polydisperse CNC sample in a relatively short analysis time of 40 min.
References
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.